| Drug Type Small molecule drug | 
| Synonyms | 
| Target | 
| Action inhibitors | 
| Mechanism Glutaminyl-peptide cyclotransferase inhibitors, QPCTL inhibitors(glutaminyl-peptide cyclotransferase like inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Inflammation | Preclinical | Germany  | 01 Feb 2025 | |
| Chronic Kidney Diseases | Preclinical | Germany  | 14 Jan 2025 | |
| Diabetic Nephropathies | Preclinical | Germany  | 14 Jan 2025 | |
| Fibrosis | Preclinical | Germany  | 14 Jan 2025 | 





